Chargement en cours...
Cardiovascular effects of dipeptidyl peptidase-4 inhibitors
Dipeptidyl peptidase-4 (DPP-4) inhibitors are effective glucose-lowering agents that do not increase body weight and are associated with a low risk for hypoglycemia. Also, they appear to exert beneficial effects on other established cardiovascular risk factors, including dyslipidemia and hypertensio...
Enregistré dans:
| Publié dans: | Hippokratia |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
SOCIETY OF "FRIENDS OF HIPPOKRATIA JOURNAL"
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4938463/ https://ncbi.nlm.nih.gov/pubmed/27418775 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|